Physician profile
Manish Ranjan
NPI 1811408891
$10,721.60
in general payments reported to CMS, 2019-2025
12 companies · $1,430 in 2025
The $1,430 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,502 · 2022: $2,962 · 2023: $2,816 · 2024: $1,011 · 2025: $1,430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,471 · Travel and Lodging: $1,786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,471.49 |
| Travel and Lodging | $1,785.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,936.52 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Insightec,INC | $1,878.10 | 2022-2023 | Exablate |
| Spr Therapeutics, INC | $856.19 | 2021-2024 | Sprint Pns System |
| Aesculap, INC. | $735.02 | 2023-2024 | Progav 2.0, Aesculap |
| Boston Scientific Corporation | $576.07 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Mml US, INC. | $573.59 | 2024-2025 | Reactiv8 |
| Mid-Atlantic Surgical Systems, LLC | $396.96 | 2025 | |
| Arthrex, INC. | $288.20 | 2025 | |
| Omniscient Neurotechnology America LTD | $248.12 | 2023 | Quicktome |
| Livanova USA, INC. | $90.48 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Nevro Corp. | $78.67 | 2022 | |
| Ethicon US, LLC | $33.63 | 2022-2025 | Surgicel Nu-Knit, Surgiflo Hemostatic Matrix, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Ranjan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.